XSpray Pharma AB (XSPRAY) — Net Asset Quality Index
XSpray Pharma AB (XSPRAY) has a Net Asset Quality Index of 77.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr736.39 Million minus total liabilities of Skr167.03 Million yields net assets of Skr569.36 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of XSpray Pharma AB to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
XSpray Pharma AB Net Asset Quality Index Over Time (2015–2025)
This chart shows how XSpray Pharma AB's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the index stands at 77.3%, representing net assets of Skr569.36 Million against total assets of Skr736.39 Million SEK. See XSPRAY net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for XSpray Pharma AB (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for XSpray Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of XSpray Pharma AB.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.6% | Skr604.65 Million | Skr769.35 Million | Skr164.70 Million | ▲ +0.3 pp |
| 2024 | 78.2% | Skr623.10 Million | Skr796.34 Million | Skr173.25 Million | ▼ -12.4 pp |
| 2023 | 90.6% | Skr693.41 Million | Skr765.26 Million | Skr71.85 Million | ▼ -4.4 pp |
| 2022 | 95.0% | Skr556.02 Million | Skr585.43 Million | Skr29.41 Million | ▼ 0.0 pp |
| 2021 | 95.0% | Skr591.75 Million | Skr622.90 Million | Skr31.15 Million | ▼ -1.2 pp |
| 2020 | 96.2% | Skr582.59 Million | Skr605.30 Million | Skr22.72 Million | ▲ +3.0 pp |
| 2019 | 93.3% | Skr373.71 Million | Skr400.67 Million | Skr26.96 Million | ▼ -3.3 pp |
| 2018 | 96.6% | Skr301.72 Million | Skr312.49 Million | Skr10.77 Million | ▲ +0.1 pp |
| 2017 | 96.4% | Skr155.66 Million | Skr161.41 Million | Skr5.75 Million | ▲ +6.8 pp |
| 2016 | 89.6% | Skr46.47 Million | Skr51.86 Million | Skr5.39 Million | ▲ +7.6 pp |
| 2015 | 82.0% | Skr12.26 Million | Skr14.95 Million | Skr2.69 Million | — |